Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$26.38 - $33.1 $63,338 - $79,473
-2,401 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$55.65 - $79.83 $116,197 - $166,685
2,088 Added 667.09%
2,401 $148,000
Q4 2018

Feb 01, 2019

SELL
$41.17 - $56.44 $45,698 - $62,648
-1,110 Reduced 78.0%
313 $14,000
Q3 2018

Nov 13, 2018

SELL
$52.95 - $71.34 $19,909 - $26,823
-376 Reduced 20.9%
1,423 $80,000
Q2 2018

Jul 20, 2018

BUY
$56.38 - $68.08 $2,537 - $3,063
45 Added 2.57%
1,799 $120,000
Q1 2018

May 08, 2018

BUY
$56.98 - $72.41 $2,849 - $3,620
50 Added 2.93%
1,754 $102,000
Q4 2017

Feb 07, 2018

SELL
$53.3 - $74.56 $33,792 - $47,271
-634 Reduced 27.12%
1,704 $110,000
Q3 2017

Oct 19, 2017

BUY
$43.46 - $52.49 $101,609 - $122,721
2,338
2,338 $123,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $950M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.